PGENYPGENYOTC
Loading
Revenue (LTM)
$114.5B
+9.9% YoY
Net Income (LTM)
$9.0B
+7.4% YoY
Free Cash Flow
$10.8B
Revenue CAGR (5Y)
+2.9%
—Marginsstable
|FCF$10.8B
|Profitable
Income Statement
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 93,080 | 94,921 | 94,461 |
| Gross Profit | 44,072 | 44,834 | 45,453 |
| Operating Income | 13,336 | 12,195 | 10,726 |
| Net Income | 8,785 | 8,581 | 7,423 |
| EBITDA | 17,498 | 17,143 | 16,331 |
| EPS Diluted | 18.36 | 17.93 | 15.52 |
Balance Sheet
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 35,218 | 34,283 | 34,357 |
| Total Current Assets | 66,254 | 67,143 | 64,800 |
| Total Assets | 98,041 | 101,733 | 100,440 |
| Total Current Liabilities | 15,072 | 15,563 | 13,532 |
| Total Liabilities | 21,232 | 21,781 | 19,353 |
| Total Equity | 73,884 | 76,695 | 77,581 |
| Total Debt | 1,935 | 2,057 | 1,900 |
| Net Debt | -33,283 | -32,226 | -32,457 |
Cash Flow Statement
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 10,893 | 13,210 | 14,503 |
| Capital Expenditure | -5,893 | -5,564 | -5,650 |
| Free Cash Flow | 5,000 | 7,646 | 8,873 |
| Stock-Based Comp | 0 | 0 | 0 |
| Net Change in Cash | -1,832 | -935 | 74 |
Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down